PAND

Pandion Therapeutics (PAND)

Pandion Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PAND

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/05/18	05 : 40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/12	19 : 55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/09	06 : 25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/06	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/06	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	22 : 54	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/02	08 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 49	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 47	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 44	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 38	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	21 : 26	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:PAND	Pandion Therapeutics Inc
2021/04/01	05 : 03	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/23	05 : 32	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/23	05 : 22	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/13	07 : 05	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/05	07 : 16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/05	06 : 49	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:PAND	Pandion Therapeutics Inc
2021/03/05	06 : 35	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:PAND	Pandion Therapeutics Inc